This company listing is no longer active
Applied Genetic Technologies Balance Sheet Health
Financial Health criteria checks 3/6
Key information
92.6%
Debt to equity ratio
US$16.34m
Debt
| Interest coverage ratio | n/a |
| Cash | US$34.24m |
| Equity | US$17.65m |
| Total liabilities | US$39.69m |
| Total assets | US$57.33m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2GT's short term assets ($37.2M) exceed its short term liabilities ($26.6M).
Long Term Liabilities: 2GT's short term assets ($37.2M) exceed its long term liabilities ($13.1M).
Debt to Equity History and Analysis
Debt Level: 2GT has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 2GT's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2GT has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 2GT has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.4% each year